In this episode of Molecule to Market, your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest Richard Johnson, Founding Director of Upperton Pharma Solutions. With more than 25 years of experience in the industry, Richard is a founding director of two, successful pharmaceutical companies. He has authored 30 scientific publications and is the named-inventor on more than 20 patents. His research experience spans a broad range of scientific disciplines particularly in the field of pharmaceutical spray drying and drug delivery. This knowledge has been used in the successful development of a number of pharmaceutical products from early research to testing on patients.


Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Richard, covering:


Greater collaboration and alliance between smaller, specialist early phase contract service providers as a way to compete against the global one-stop-shops.
Increased demand for nasal and pulmonary delivery as a result oft the pandemic. And why Richard was not surprised to see a Covid-19 vaccine developed so quickly.
The contrast of founding a steady 20-year growth business and the another that exited in just five years.
The increasing demand and application for spray drying technology to solve modern pharmaceutical development challenges.



Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.